Vice President, Head of Research, Xios Therapeutics
Jannik has multidisciplinary background in chemical engineering (M.Sc) and human biology (Ph.D). He has spent his professional career working in drug discovery in pharma (Novo Nordisk & Merck), Biotech (XTuit Pharmacuticals & Xios Therapeutics) and at leading university hospitals...
Read More →PK
Director of Biomarkers and Companion Diagnostics, H3 Biomedicine, Inc.
Pavan has been part of the Biomarkers and Diagnostics industry for over 10 years, and is currently responsible for development and execution of clinical biomarker and translation strategies for multiple oncology programs, with special emphasis on liquid biopsies and multiplexed biomarker...
Read More →
Director, Regulatory Affairs, Oncology Business Group, Eisai Inc.
Within Eisai, Sabah’s responsibilities include developing and delivering effective regulatory strategies to support development of therapeutics, especially those utilizing biomarkers or companion diagnostics (CDx) and managing global regulatory submissions. Prior to this, Sabah...
Read More →
Senior Consultant and Nonclinical Group Leader, Biologics Consulting
Dr. David Pepperl is a Sr. Consultant and nonclinical group leader at Biologics Consulting in Alexandria, VA, and has 20 years’ experience in nonclinical development of drugs and biologics. With a background in both pharmacology/toxicology and cell and molecular biology, Dr. Pepperl...
Read More →